Trial Profile
Fesoterodine ameliorates the activity in frontal brain micturition area and the hypersensibility of bladder afferent nerves in patients with OAB symptoms.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2014
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Pharmacodynamics
- 10 Mar 2014 New trial record